FBInvestor
Stocks / Lantern Pharma Inc
Institutional Ownership

Lantern Pharma Inc

CUSIP 51654W101COMLTRNQ1 2026

Institutional Holders
29
13F filers
Shares Held
1.69M
Aggregate institutional
Institutional Value
$2.31M
Q1 2026
Net New Holders
-2
2 new · 4 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions2
Increased9
Decreased8
Sold out4

Institutional Holders

29 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Bios Capital Management, LP864.4K$1.18M145.1KReduced
2Cm Management, LLC250.0K$342.5K+25.0KAdded
3Renaissance Technologies LLC116.0K$158.9K+5.6KAdded
4Geode Capital Management, LLC111.6K$153.0K+14.9KAdded
5Westside Investment Management, Inc.50.0K$68.6K+14.2KAdded
6Voss Capital, LP50.0K$68.5K0Held
7Blackrock, Inc.45.3K$62.0K+1.0KAdded
8Dimensional Fund Advisors LP38.1K$52.1K1.1KReduced
9Horizon Kinetics Asset Management LLC26.4K$36.1K1.2KReduced
10Davenport & Co LLC23.8K$32.6K0Held

19 more institutional holders on Premium

See every fund holding Lantern Pharma Inc, with full quarter-over-quarter share changes.

Unlock all holders